Standardizing disinfectant wipes across multiple facilities requires comparing active ingredients, kill claims, and dwell times.
With over 300 facilities in one health care system, how does an infection preventionist (IP) narrow down the many options for disinfectant wipes while keeping both health care workers and the medical equipment safe?
Maria Montero, MPH, MT(ASCP)SM, CIC, FAPIC, IP, Northwestern Medicine Delnor Hospital, researched this topic for her health care system and spoke to Infection Control Today® (ICT®) about the study for which she was lead author, “Standarizing Disinfectant Wipes Across a Hospital Setting" recently published in the American Journal of Infection Control. Montero discusses how she and her team reduced the number of types of wipes used in the facilities they studied, the future research she has planned, and what needs to be updated and corrected concerning disinfection wipes in the 11 hospitals and over 300 ambulatory sites she and her colleagues studied.
“The importance [of the study] was to make sure that clinical staff were using cleaning and disinfecting surfaces and medical equipment appropriately, correctly following the correct contact times using the appropriate disinfectant wipes,” Montero told ICT® in the exclusive interview. “When we started this, there was a mixture of different types of wipes different chemicals. It was very difficult when we asked staff, “How do you clean this piece of equipment?” for them to remember the appropriate dwell time for each wipe that they used. We found this very important to standardize our disinfectant wipes across the system. When COVID-19 came, the pandemic enforced the importance of doing this because we started having difficulty securing disinfecting wipes.”
Another key point that Montero made was the safety and efficacy of the wipes used on the various equipment in the many facilities she and her team studied. In order to find the safest and most efficient wipe, she told ICT®, “We partnered with our vendor, and we shared the top 10 pieces of equipment that we used across the system, and they did a crosswalk in [to verify the wipes were safe]."
Montero said that for some of the wipes, the equipment or wipes were so new that there was no documentation yet to verify their efficacy or safety. However, “the vendor was instrumental in helping us with determining if the product was going to be safe for that piece of equipment.”
Four Years After COVID-19: What Has the Infection Prevention Community Learned?
March 15th 2024Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
“A Marathon and a Sprint”: Passing Surgical Smoke Legislation
March 9th 2024At the AORN’s International Surgical Conference & Expo 2024, a presentation on surgical smoke drew applause and strong emotion about the continuing fight for legislation on removing surgical smoke from operating rooms. Infection Control Today was there to tell you what happened.
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.